MettangT., FritzP., WeberJ., MachleidtC., HubelE., KuhlmannU.. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol1990; 3: 136–41.
9.
RollinoC., GoitreM., PiccoliG.What is the role of sensitization in uremic pruritus?Nephron1991; 57: 319–22.
10.
MassryS.G., PopovzerM.N., CoburnJ.W., MakoffD.L., MaxwellM.H., KleemanC.R.. Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching following subtotal parat-hyroidectomy. New Engl J Med1968; 279: 697–700.
11.
MassryS.G., CoburnJ.W., Har-tenbowerD.L.Mineral content of human skin in uremia. Effect of secondary hyperparathyroidism and hemodialysis. EDTA Proc1970; VII: 146–50.
12.
AltmeyerP., KachelH.G., Juen-gerM., KochK.M., HolzmannH.. Hautveraenderungen bei Lan-gzeitdialysepatienten. Eine klinische Studie. Hautarzt1982; 33(6): 303–9.
13.
CarmichaelA.J., Mc HughM.M., MartinA.M.. Serological markers of renal itch in patients receiving long term hemodialysis. Br. Med. J, 1988; 296: 1575.
14.
YoungA.W., SweeneyE.W., DavidD.S.Dermatologic evaluation of pruritus in patients on hemodialysis. NY St J Med1973; 73: 2670–4.
15.
CoburnJ.W., SlatopolskyE.. Vit. D, parathyroid hormone and renal osteodistrophy. In BrennerRector eds. The Kidney.Saunders WB, Philadelphia, 1981, pp. 22–60.
16.
GrafH., KovarikJ., StummvullH.K., WolfA.. Disappearance of uraemic pruritus after lowering dialysate magnesium concentration. Br Med J1979; ii: 1478–9.
17.
CarmichaelA.J., DickinsonF., Mc HughM.I.. Magnesium-free dialysis for uraemic pruritus. Br Med J1988; 297: 1584–5.
18.
SchultzB.C., RoenigkH.H.. Jr. Uremic pruritus treated with ultraviolet light. JAMA1980; 243: 1836–7.
19.
Della VolpeM., GattoR., Fiande-sioD.Fototerapia del prurito uremico. Atti I Convegno di Nefrologiae Dialisi (Torre Pellice, 21-22 aprile 1981): 127–9.
VahlquistA., PetersonP.A., Wi-bellL.. Metabolism of the vitamin A transporting complex I. Turnovers studies in normal persons and in patients with chronic renal failure. Eur. J Clin. Invest.1973; 3: 352–62.
22.
KelleherJ., HumphreyC.S., HomerD., DavisonA.M., GilesG.R., LosowskyM.S.. Vitamin A and its transport proteins in patients with chronic renal failure receiving maintenance hemodialysis and after renal transplantation. Clin. Sci.1983; 65: 619–26.
23.
VahlquistA., BerneB., BerneC.. Skin content and plasma transport of vitamin A and beta carotene in chronic renal failure. Eur J Clin Invest1982; 12: 63–7.
24.
BleehenS.S.. Metabolic and nutritional desorders. In: Rook, Wilkinson, Ebling eds. Textbook of dermatology.Blackwell, Oxford, 1979; 2087–8.
25.
DelacouxE., EvstigneeffT., Le-clerqM.Skin desorders and vitamin A metabolism disturbance in chronic dialysis patients: the role of zinc, retinol-binging protein, retinol and reti-noic acidClin Chim Acta1984; 137: 283–9.
26.
Dalla PiccolaB., TataranniG., FarinelliA.. Uremia and mast cells proliferation. Lancet1972; i: 1231.
27.
CawleyE.P.. A surfeit of mast cells in the skin of patients with uremia. Arch Dermatol1975; 111: 1663–6.
28.
MatsumotoM., IchimaruK., HorieA.. Pruritus and mast cell proliferation of the skin in end stage renal failure. Clin. Nephrol.1985; 6: 285–8.
29.
SchauerA.. Histamin-Effecte auf Organsysteme. Die Mastzelle Morphologie und Funkionen. In: Doenicke A, Histamin and Histamin-Rezeptor-Antagoni-sten.Springer-Verlag, London, 1985, 93–120.
30.
StockenhuberF., Sunder-PlasmannG., BalckeP.. Increased plasma histamine levels in chronic renal failure (Letter). New Engl. J Med.1987; 317: 386.
BeavenM., Robinson-WhiteA., RoderikN.B., KauffmenG.L.. The demonstration of histamine release in clinical conditions: a review of the past and pesent assay procedures. Klin Wo-chenschr1985; 40(3): 316–21.
33.
DaviesM.G., GreavesM.W.. Sensory responses of human skin to synthetic histamine analogues and histamine. Brit J Clin Pharmacol1980; 9: 461–5.
34.
JagemarkO.. Studies on experimental itch produced by kallik-rein and bradykinin. Acta Der-matovenereol.1974; 54: 397–400.
35.
GreavesM.W.. Itch: role of prostaglandins. Brit Med J1973; 2: 608–9.
36.
LovellC.R.. Prostaglandins and pruritus. Brit J Dermatol1976; 94: 273–7.
37.
HagemarkO.. Fjellner B. Enhancement of histamine-induced pruritus by enkephalin and morphine. J Invest Dermatol1980; 74: 459.
38.
GattiS.. Serri F. Il prurito nella pratica medica: fisiopatologia, clinica e terapia.Fondazione pro ricerca dermatologica, Roma, 1984.
39.
SnyderS.M.. Opiate receptors in the brain. N Engl J Med1977; 296: 266–71.
40.
GmerekD.E., CowanA.. Bombesin: a central mediator of pruritus? Brit. J Dermatol1983; 109: 239–43.
41.
KesslerM., Moneret-VautrinD.A., ForetM.. Bioincompatibilité de l'hémodialyses. I: Les aspects aigus. Rev. Fr. Allergol.1985; 4: 205–9.
42.
MariotA., Moneret-VautrinD.A., KesslerM.. Les hypersensibilités retardées aux réactogènes chimiques chez les hemodialyses. Rev. Fr. Allergol.1986; 26: 15–8.
TapiaL.. Cheing JS, David DS, Sullivan JF. Pruritus in dialysis patients treated with parenteral lidocaine. New Engl J Med1977; 296: 261–2.
53.
SnyderD., MerrillJ.P.. Sauna baths in the treatment of chronic renal failure. Trans Am. Soc. Artif. Intern. Organs.1966; 12: 188.
54.
MyonthantS., MasadaH., HasadaH.Primary skin care. Possible control of urticarial dermatitis (urticaria) and skin itching by the method of electrical stimulations through the acupunture needles. Jap J Ryo-doraku Autom Nerv Sys1981; 26: 285–308.
55.
DuoL.J.Electrical needle therapy of uremic pruritus. Nephron1987; 47: 179–83.
56.
GilchrestB.A., RoweJ.W., BrownR.S., SteinmanT.I., ArndtK.A.. Relief of uremic pruritus with ultraviolet phototherapy. New Engl J Med1978; 297: 136–8.
57.
GilchrestB.A., RoweJ.W., BrownR.S., SteinmenT.I., ArndtK.A.. Ultraviolet phototherapy of u-remiuc pruritus. Ann. Intern. Med.1979; 91: 17–21.
58.
TaylorR., TaylorA.E.M., DiffeyB.L., HindsonT.C.. A placebo controlled trial of UVA phototherapy for the treatment of uremic pruritus. Nephron.1983; 33: 14–6.
59.
ChangT.M.S.. Microcapsule artificial kidney in replacement of renal function with emphasis on abssorbent hemoperfusion. In: Drukker, Parsons, Maher eds. Replacement of renal function by dialysis.Martinus Nijoff, The Hague, 1979, pp. 217–31.
60.
ChangT.M.S.. Assessment of clinical trials of charcoal hemoperfusion in uremic patients. Clin Nephrol1979; 11: 111–9.
61.
ChangT.M.S.. Artificial cells in hemoperfusion and other applications. Nephron1984; 36: 161–8.
62.
BonominiV., StefoniS., Felician-geliG.L'emoperfusione con carbone attivato nel trattamento sostitutivo artificiale dell'uremia cronica: 5 anni di applicazione clinica. Nefrol Dial Trap (XXIII Congr Naz Soc It Nefrol), Wichtig, Milano 1982, pp. 303–6.
63.
BonominiV., StefoniS., Felician-geliG., ColiL.. Hemoperfusion in uremia. In: Piskin, chang, The past present and future of artificial organs.Meteksan, Ankara, 1983; pp. 170–9.
64.
GhezziP.M., GrivetV., Malcagni. Il prurito uremico: trattamento con emodialisi-emoper-fusione associate. In: RamelloMalcangi eds. Moderne acquisizioni in nefrologia e dialisi.Monduzzi, Bologna, 1988, pp. 457–67.